Cost–Utility Analysis of a Medication Adherence Management Service Alongside a Cluster Randomized Control Trial in Community Pharmacy

References

• Mair A, Wilson M, Dreischulte T. Addressing the challenge of polypharmacy. Annu Rev Pharmacol Toxicol. 2020;60(1):661–681. doi:10.1146/annurev-pharmtox-010919-023508
   PubMed Web of Science ®Google Scholar
• Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization; 2003.
   Google Scholar
• Blaschke TF, Osterberg L, Vrijens B, Urquhart J. Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol. 2012;52(1):275–301. doi:10.1146/annurev-pharmtox-011711-113247
   PubMed Web of Science ®Google Scholar
• Khan R, Socha-Dietrich K. Investing in medication adherence improves health outcomes and health system efficiency: Adherence to medicines for diabetes, hypertension, and hyperlipidaemia. OECD Health Working Papers, No. 105, 2018; OECD Publishing, Paris. doi:10.1787/8178962c-en
   Google Scholar
• Senior International Health Association - SIHA. European charter on adherence to therapy; 2016. Available from: https://www.seniorinternationalhealthassociation.org/wp-content/uploads/2016/11/European-Charter-on-Adherence-to-Therapy-web.pdf. Accessed October 9, 2021.
   Google Scholar
• Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8(1):e016982. doi:10.1136/bmjopen-2017-016982
   PubMed Web of Science ®Google Scholar
• Vrijens B, Antoniou S, Burnier M, de la Sierra A, Volpe M. Current situation of medication adherence in hypertension. Front Pharmacol. 2017;8:100. doi:10.3389/fphar.2017.00100
   PubMed Web of Science ®Google Scholar
• Mes MA, Katzer CB, Chan AHY, Wileman V, Taylor SJC, Horne R. Pharmacists and medication adherence in asthma: a systematic review and meta-analysis. Eur Respir J. 2018;52(2):1800485. doi:10.1183/13993003.00485-2018
   PubMed Web of Science ®Google Scholar
• Mueller S, Wilke T, Bechtel B, Punekar YS, Mitzner K, Virchow JC. Non-persistence and non-adherence to long-acting COPD medication therapy: a retrospective cohort study based on a large German claims dataset. Respir Med. 2017;122:1–11. doi:10.1016/j.rmed.2016.11.008
   PubMed Web of Science ®Google Scholar
• Mennini FS, Marcellusi A, von der Schulenburg JM, et al. Cost of poor adherence to anti-hypertensive therapy in five European countries. Eur J Health Econ. 2015;16(1):65–72. doi:10.1007/s10198-013-0554-4
   PubMed Web of Science ®Google Scholar
• Kirkland EB, Heincelman M, Bishu KG, et al. Trends in healthcare expenditures among US adults with hypertension: national estimates, 2003–2014. J Am Heart Assoc. 2018;7(11):e008731. doi:10.1161/JAHA.118.008731.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention; 2020. Online Appendix. Available from: https://ginasthma.org/reports/ . Accessed October 9, 2021P
   Google Scholar
• European Respiratory Society. European lung white book. Chapter 2. The economic burden of lung disease. Available from: https://www.erswhitebook.org/chapters/the-economic-burden-of-lung-disease/. Accessed October 6, 2021.
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (2020 report); 2020. Available from: https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf. Accessed October 9, 2021
   Google Scholar
• Wiecek E, Tonin FS, Torres-Robles A, Benrimoj SI, Fernandez-Llimos F, Garcia-Cardenas V. Temporal effectiveness of interventions to improve medication adherence: a network meta-analysis. PLoS One. 2019;14(3):e0213432. doi:10.1371/journal.pone.0213432
   PubMed Web of Science ®Google Scholar
• Anderson LJ, Nuckols TK, Coles C, et al. A systematic overview of systematic reviews evaluating medication adherence interventions. Am J Health Syst Pharm. 2020;77(2):138–147. doi:10.1093/ajhp/zxz284
   PubMed Web of Science ®Google Scholar
• Simon-Tuval T, Neumann PJ, Greenberg D. Cost-effectiveness of adherence-enhancing interventions: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2016;16(1):67–84. doi:10.1586/14737167.2016.1138858
   PubMed Web of Science ®Google Scholar
• Cross AJ, Elliott RA, Petrie K, Kuruvilla L, George J. Interventions for improving medication‐taking ability and adherence in older adults prescribed multiple medications. Cochrane Database Syst Rev. 2020;(5). doi:10.1002/14651858.CD012419.pub2
   Web of Science ®Google Scholar
• Marcum ZA, Hanlon JT, Murray MD. Improving medication adherence and health outcomes in older adults: an evidence-based review of randomized controlled trials. Drugs Aging. 2017;34(3):191–201. doi:10.1007/s40266-016-0433-7
   Web of Science ®Google Scholar
• Conn VS, Ruppar TM. Medication adherence outcomes of 771 intervention trials: systematic review and meta-analysis. Prev Med. 2017;99:269–276. doi:10.1016/j.ypmed.2017.03.008
   PubMed Web of Science ®Google Scholar
• Milosavljevic A, Aspden T, Harrison J. Community pharmacist-led interventions and their impact on patients’ medication adherence and other health outcomes: a systematic review. Int J Pharm Pract. 2018;26(5):387–397. doi:10.1111/ijpp.12462
   PubMed Web of Science ®Google Scholar
• Omboni S, Caserini M. Effectiveness of pharmacist’s intervention in the management of cardiovascular diseases. Open Heart. 2018;5(1):e000687. doi:10.1136/openhrt-2017-000687
   PubMed Web of Science ®Google Scholar
• Readdean KC, Heuer AJ, Scott Parrott J. Effect of pharmacist intervention on improving antidepressant medication adherence and depression symptomology: a systematic review and meta-analysis. Res Social Adm Pharm. 2018;14(4):321–331. doi:10.1016/j.sapharm.2017.05.008
   PubMed Web of Science ®Google Scholar
• Dokbua S, Dilokthornsakul P, Chaiyakunapruk N, Saini B, Krass I, Dhippayom T. Effects of an asthma self-management support service provided by community pharmacists: a systematic review and meta-analysis. J Manag Care Spec Pharm. 2018;24(11):1184–1196. doi:10.18553/jmcp.2018.24.11.1184
   Web of Science ®Google Scholar
• International Pharmaceutical Federation (FIP). Use of Medicines by the Elderly: The Role of Pharmacy in Promoting Adherence. The Hague: International Pharmaceutical Federation; 2018.
   Google Scholar
• Doggrell SA. A review of interventions ≥ 6 months by pharmacists on adherence to medicines in cardiovascular disease: characteristics of what works and what doesn’t. Res Social Adm Pharm. 2019;15(2):119–129. doi:10.1016/j.sapharm.2018.04.003
   PubMed Web of Science ®Google Scholar
• Presley B, Groot W, Pavlova M. Pharmacy-led interventions to improve medication adherence among adults with diabetes: a systematic review and meta-analysis. Res Social Adm Pharm. 2019;15(9):1057–1067. doi:10.1016/j.sapharm.2018.09.021
   PubMed Web of Science ®Google Scholar
• Newman TV, San-Juan-Rodriguez A, Parekh N, et al. Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes: an umbrella review. Res Social Adm Pharm. 2020;16(9):1155–1165. doi:10.1016/j.sapharm.2019.12.016
   PubMed Web of Science ®Google Scholar
• Jia X, Zhou S, Luo D, Zhao X, Zhou Y, Cui Y. Effect of pharmacist‐led interventions on medication adherence and inhalation technique in adult patients with asthma or COPD: a systematic review and meta‐analysis. J Clin Pharm Ther. 2020;45(5):1–14.
   Web of Science ®Google Scholar
• Lelubre M, Kamal S, Genre N, et al. Interdisciplinary medication adherence program: the example of a University Community Pharmacy in Switzerland. Biomed Res Int. 2015;2015:103546. doi:10.1155/2015/103546
   PubMed Web of Science ®Google Scholar
• Van der laan DM, Elders PJM, Boons CCLM, Nijpels G, Dijk L, Hugtenburg JG. Effectiveness of a patient-tailored, pharmacist-led intervention program to enhance Adherence to antihypertensive medication: the CATI study. Front Pharmacol. 2018;9:1057. doi:10.3389/fphar.2018.01057
   Web of Science ®Google Scholar
• Bosmans JE, van der Laan DM, Yang Y, et al. The cost-effectiveness of an intervention program to enhance adherence to antihypertensive medication in comparison with usual care in community pharmacies. Front Pharmacol. 2019;10:210. doi:10.3389/fphar.2019.00210
   PubMed Web of Science ®Google Scholar
• van Boven JFM, Stuurman-Bieze AGG, Hiddink EG, Postma MJ, Vegter S. Medication monitoring and optimization: a targeted pharmacist program for effective and cost-effective improvement of chronic therapy adherence. J Manag Care Pharm. 2014;20(8):786–792. doi:10.18553/jmcp.2014.20.8.786
   PubMed Web of Science ®Google Scholar
• van Boven JF, Stuurman-Bieze AG, Hiddink EG, Postma MJ. Effects of targeting disease and medication management interventions towards patients with COPD. Curr Med Res Opin. 2016;32(2):229–239. doi:10.1185/03007995.2015.1110129
   PubMed Web of Science ®Google Scholar
• Manfrin A, Tinelli M, Thomas T, Krska J. A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients. BMC Health Serv Res. 2017;17(1):300. doi:10.1186/s12913-017-2245-9
   Web of Science ®Google Scholar
• Elliott RA, Boyd MJ, Salema NE, et al. Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service. BMJ Qual Saf. 2016;25(10):747–758. doi:10.1136/bmjqs-2015-004400
   PubMed Web of Science ®Google Scholar
• Elliott RA, Boyd MJ, Tanajewski L, et al. “New Medicine Service”: supporting adherence in people starting a new medication for a long-term condition: 26-week follow-up of a pragmatic randomised controlled trial. BMJ Qual Saf. 2020;29(4):286–295. doi:10.1136/bmjqs-2018-009177
   Web of Science ®Google Scholar
• Twigg MJ, Wright D, Barton G, Kirkdale CL, Thornley T. The pharmacy care plan service: evaluation and estimate of cost-effectiveness. Res Social Adm Pharm. 2019;15(1):84–92. doi:10.1016/j.sapharm.2018.03.062
   PubMed Web of Science ®Google Scholar
• Foro de Atención Farmacéutica en Farmacia Comunitaria [Forum of Pharmaceutical Care in Community Pharmacy]. Guía práctica para los Servicios Profesionales Farmacéuticos Asistenciales en la Farmacia Comunitaria [A Practical Guide to Professional Pharmaceutical Care Services in Community Pharmacy]. Madrid: Consejo General de Colegios Oficiales de Farmacéuticos; 2019.
   Google Scholar
• Martinez-Martinez F. Informe global 2019 adherenciaMED: diseño, evaluación del impacto e implantación de un servicio profesional de adherencia terapéutica desde el ámbito de la farmacia comunitaria [2019 AdherenciaMED global report: design, impact evaluation and implementation of a professional medication adherence service from community pharmacy setting]. Madrid: Consejo General de Colegios Oficiales de Farmacéuticos; 2019.
   Google Scholar
• Torres-Robles A, Benrimoj SI, Gastelurrutia MA, et al. Effectiveness of a medication adherence management intervention in a community pharmacy setting: a cluster randomised controlled trial. BMJ Qual Saf. 2021:bmjqs-2020-011671. doi:10.1136/bmjqs-2020-011671
   Web of Science ®Google Scholar
• Husereau D, Drummond M, Petrou S, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force. Value Health. 2013;16(2):231–250. doi:10.1016/j.jval.2013.02.002
   PubMed Web of Science ®Google Scholar
• Instituto Nacional de Estadística [National Statistics Institute]. Cálculo de variaciones del indice de precios de consumo (sistema IPC base 2016) [Calculation of the Consumer Price Index percentage changes (CPI system base 2016)]. Available from: https://www.ine.es/varipc/index.do. Accessed October 6, 2021.
   Google Scholar
• Pérez-Escamilla B, García-Cárdenas V, Gastelurrutia M, et al. Percepción de los formadores colegiales sobre el futuro profesional de esta nueva figura laboral en la farmacia comunitaria [Perception of Practice Change Facilitators on the professional future of this new job in community pharmacy]. Pharm Care Espana. 2014;16(3):81–88.
   Google Scholar
• Cranley LA, Cummings GG, Profetto-McGrath J, Toth F, Estabrooks CA. Facilitation roles and characteristics associated with research use by healthcare professionals: a scoping review. BMJ Open. 2017;7(8):e014384. doi:10.1136/bmjopen-2016-014384
   Web of Science ®Google Scholar
• Albers B, Metz A, Burke K. Implementation support practitioners - A proposal for consolidating a diverse evidence base. BMC Health Serv Res. 2020;20(1):368. doi:10.1186/s12913-020-05145-1
   Web of Science ®Google Scholar
• WHO Collaborating Centre for Drug Statistics Methodology. Anatomical, therapeutic, chemical. Structure and principles; February 15, 2018. Available from: https://www.whocc.no/atc/structure_and_principles/. Accessed October 6, 2021.
   Google Scholar
• Base de Datos de Medicamentos - BotPlus 2.0. General pharmaceutical council of Spain. Available from: https://botplusweb.portalfarma.com/. Accessed April 30, 2018.
   Google Scholar
• Spanish General Access Point. Autonomous Communities [Comunidades autónomas] - Organization of the Spanish state. Administracion.gob.es; 2021. Available from: https://administracion.gob.es/pag_Home/en/espanaAdmon/comoSeOrganizaEstado/ComunidadesAutonomas.html#.YCEAk_mCHIV. Accessed February 8, 2021.
   Google Scholar
• Boletín Oficial de Castilla y León. Decreto 83/2013, de 26 de diciembre, por el que se actualizan los precios públicos de la Comunidad de Castilla y León y la tasa por actuaciones administrativas relativas a actividades agrícolas; [Official Gazette of Castilla y León. Decree 83/2013, of December 26, which updates the public prices of the Community of Castilla y León and the fee for administrative actions related to agricultural activities]. 2013. Available from: http://bocyl.jcyl.es/html/2013/12/30/html/BOCYL-D-30122013-6.do. Accessed October 6, 2021.
   Google Scholar
• Diario Oficial de Castilla La Mancha. Orden de 17/11/2014, de la Consejería de Sanidad y Asuntos Sociales, por la que se establecen los precios públicos de la asistencia sanitaria y de los servicios prestados en la red de centros sanitarios dependientes del Servicio de Salud de Castilla-La Mancha; [Official Gazette of Castilla La Mancha. Order of 17/11/2014, of the Regional Ministry of Health and Social Affairs, establishing the public prices for healthcare and services provided in the network of healthcare centers dependent on the Castilla-La Mancha Health Service]. 2014. Available from: https://docm.jccm.es/portaldocm/descargarArchivo.do?ruta=2014/11/21/pdf/2014_15022.pdf&tipo=rutaDocm. Accessed October 6, 2021.
   Google Scholar
• Diario Oficial de Galicia. Decreto 56/2014, de 30 de abril, por el que se establecen las tarifas de los servicios sanitarios prestados en los centros dependientes del Servicio Gallego de Salud y en las fundaciones públicas sanitarias; [Official Gazette of Galicia. Decree 56/2014, of April 30, establishing the rates for health services provided in the centers dependent on the Galician Health Service and in the public health foundations]. 2014. Available from: https://www.xunta.gal/dog/Publicados/2014/20140521/AnuncioC3K1-140514-0001_es.html. Accessed October 6, 2021.
   Google Scholar
• Boletín Oficial de Canarias. Resolución de 29 de marzo de 2017, del Director, por la que se modifica la cuantía de los precios públicos de servicios sanitarios previstos en el Decreto 81/2009, de 16 de junio, por el que se establecen los precios públicos de los servicios sanitarios prestados por el Servicio Canario de la Salud y se fijan sus cuantías [Official Gazette of the Canary Islands. Resolution of March 29, 2017, of the Director, modifying the amount of the public prices of health services provided for in Decree 81/2009, of June 16,  by which the public prices of the healthcare services provided by the Canary Health Service are established and their amounts are set.]; 2017. Avaiblable from: http://www.gobiernodecanarias.org/boc/2017/067/002.html. Accessed October 14, 2021.
   Google Scholar
• Ministerio de Sanidad CyBS. Costes hospitalarios, resultados estadísticos anuales, año 2017. Resultados según la versión 32 de los APR-GRD. Pesos y coste hospitalarios para cada nivel de severidad y por GRD basal [Ministry of Health CyBS. Hospital costs, annual statistical results, year 2017. Results according to version 32 of the APR-GRD. Hospital weights and cost for each severity level and by baseline GRD]; 2017. Available from: https://www.mscbs.gob.es/estadEstudios/estadisticas/inforRecopilaciones/anaDesarrolloGDR.htm. Accessed October 6, 2021.
   Google Scholar
• Boletin Oficial del Estado. Resolución de 9 de abril de 2014, de la dirección general de empleo, por la que se registra y publica el laudo arbitral para oficinas de farmacia [Official State Gazette. Resolution of April 9, 2014, of the Directorate General of Employment, which registers and publishes the arbitration award for pharmacy offices]; 2014. Available from: https://www.boe.es/eli/es/res/2014/04/09/(5). Accessed October 14, 21
   Google Scholar
• Noain A, Garcia-Cardenas V, Gastelurrutia MA, et al. Cost analysis for the implementation of a medication review with follow-up service in Spain. Int J Clin Pharm. 2017;39(4):750–758. doi:10.1007/s11096-017-0454-2
   Web of Science ®Google Scholar
• Badia X, Roset M, Montserrat S, Herdman M, Segura A. [The Spanish version of EuroQol: a description and its applications. European quality of life scale]. Med Clin. 1999;112(Suppl 1):79–85. Spanish.
   PubMed Web of Science ®Google Scholar
• Ramos-Goñi JM, Pinto-Prades JL, Oppe M, Cabasés JM, Serrano-Aguilar P, Rivero-Arias O. Valuation and modeling of EQ-5D-5L health states using a hybrid approach. Med Care. 2017;55(7):e51–e58. doi:10.1097/MLR.0000000000000283
   PubMed Web of Science ®Google Scholar
• Drummond MF, O’brien BJ, Stoddart GL, Torrance GW. Métodos Para La Evaluación Económica De Los Programas De Asistencia Sanitaria[Methods for the Economic Evaluation of Health Care Programmes]. Ediciones Díaz de santos; 2001.
   Google Scholar
• Faria R, Gomes M, Epstein D, White IR. A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials. Pharmacoeconomics. 2014;32(12):1157–1170. doi:10.1007/s40273-014-0193-3
   PubMed Web of Science ®Google Scholar
• O’Brien BJ, Briggs AH. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Stat Methods Med Res. 2002;11(6):455–468. doi:10.1191/0962280202sm304ra
   Web of Science ®Google Scholar
• Vallejo-Torres L, García-Lorenzo B, Serrano-Aguilar P. Estimating a cost-effectiveness threshold for the Spanish NHS. Health Econ. 2018;27(4):746–761. doi:10.1002/hec.3633
   PubMed Web of Science ®Google Scholar
• Gastelurrutia MA, Faus MJ, Martínez-Martínez F. Primary health care policy and vision for community pharmacy and pharmacists in Spain. Pharm Pract. 2020;18(2). doi:10.18549/pharmpract.2020.2.1999
   Web of Science ®Google Scholar
• Pharmaceutical Services Negotiating Committee. The value of community pharmacy – summary report; 2016. Available from: https://psnc.org.uk/wp-content/uploads/2016/09/The-value-of-community-pharmacy-summary-report.pdf. Accessed June 28, 2021.
   Google Scholar
• Gagnon-Arpin IDA, Sutherland G, Stonebridge C, Dinh T. The value of expanded pharmacy services in Canada; 2017. Available from: https://pans.ns.ca/system/files/files/page/8721_expanded_pharmacy_rpt_embargoed.pdf. Accessed October 14, 20
   Google Scholar
• Pharmaceutical Group of the European Union (PGEU). PHARMACY 2030: A Vision for Community Pharmacy in Europe; 2019. Available from: https://www.pgeu.eu/publications/pharmacy-2030-a-vision-for-community-pharmacy-in-europe/. Accessed October 14, 2021
   Google Scholar
• van Boven JF, Tommelein E, Boussery K, et al. Improving inhaler adherence in patients with chronic obstructive pulmonary disease: a cost-effectiveness analysis. Respir Res. 2014;15(1):66. doi:10.1186/1465-9921-15-66
   PubMed Web of Science ®Google Scholar
• Khdour MR, Agus AM, Kidney JC, Smyth BM, McElnay JC, Crealey GE. Cost-utility analysis of a pharmacy-led self-management programme for patients with COPD. Int J Clin Pharm. 2011;33(4):665–673. doi:10.1007/s11096-011-9524-z
   PubMed Web of Science ®Google Scholar
• Desborough JA, Sach T, Bhattacharya D, Holland RC, Wright DJ. A cost-consequences analysis of an adherence focused pharmacist-led medication review service. Int J Pharm Pract. 2012;20(1):41–49. doi:10.1111/j.2042-7174.2011.00161.x
   Google Scholar
• Elliott RA, Tanajewski L, Gkountouras G, et al. Cost effectiveness of support for people starting a new medication for a long-term condition through community pharmacies: an economic evaluation of the New Medicine Service (NMS) Compared with Normal Practice. Pharmacoeconomics. 2017;35(12):1237–1255. doi:10.1007/s40273-017-0554-9
   PubMed Web of Science ®Google Scholar
• Pringle JL, Boyer A, Conklin MH, McCullough JW, Aldridge A. The Pennsylvania project: pharmacist intervention improved medication adherence and reduced health care costs. Health Aff. 2014;33(8):1444–1452. doi:10.1377/hlthaff.2013.1398
   Web of Science ®Google Scholar
• Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;(11):Cd000011. doi:10.1002/14651858.CD000011.pub4
   PubMed Web of Science ®Google Scholar
• Waldman JD, Yourstone SA, Smith HL. Learning curves in health care. Health Care Manag Rev. 2003;28(1):41–54. doi:10.1097/00004010-200301000-00006
   Web of Science ®Google Scholar
• Pusic MV, Boutis K, Hatala R, Cook DA. Learning curves in health professions education. Acad Med. 2015;90(8):1034–1042. doi:10.1097/ACM.0000000000000681
   PubMed Web of Science ®Google Scholar
• Howard NM, Cook DA, Hatala R, Pusic MV. Learning curves in health Professions education simulation research: a systematic review. Simulat Healthc. 2021;16(2):128–135. doi:10.1097/SIH.0000000000000477
   Google Scholar
• Duncan EM, Francis JJ, Johnston M, et al. Learning curves, taking instructions, and patient safety: using a theoretical domains framework in an interview study to investigate prescribing errors among trainee doctors. Implement Sci. 2012;7(1):86. doi:10.1186/1748-5908-7-86
   PubMed Web of Science ®Google Scholar
• Tersalvi G, Vicenzi M, Kirsch K, et al. Structured telephone support programs in chronic heart failure may be affected by a learning curve. J Cardiovas Med. 2020;21(3):231–237. doi:10.2459/JCM.0000000000000934
   Web of Science ®Google Scholar
• Schilling MA, Vidal P, Ployhart RE, Marangoni A. Learning by doing something else: variation, relatedness, and the learning curve. Manage Sci. 2003;49(1):39–56. doi:10.1287/mnsc.49.1.39.12750
   Web of Science ®Google Scholar